Suppr超能文献

离子对策略控制比索洛尔的皮肤透过率,用于长效透皮贴剂。

The control of skin-permeating rate of bisoprolol by ion-pair strategy for long-acting transdermal patches.

机构信息

Department of Pharmaceutical Sciences, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang, Liaoning, 110016, China.

出版信息

AAPS PharmSciTech. 2012 Sep;13(3):811-5. doi: 10.1208/s12249-012-9808-1. Epub 2012 May 26.

Abstract

A moderate drug permeating rate (flux) is desirable for long-acting transdermal patches. In this work, a novel simple method of controlling bisoprolol (BSP) flux by ion-pair strategy was initiated. Different ion-pair complexes including bisoprolol maleate (BSP-M), bisoprolol tartarate, bisoprolol besilate, and bisoprolol fumarate were prepared and their fluxes through rabbit abdominal skin were determined separately in vitro. Furthermore, permeation behavior from isopropyl myristate, solubility index in pressure-sensitive adhesives, determined by DSC, and n-octanol/water partition coefficient (log P) were investigated to illustrate the mechanism of drug permeation rate controlling. The results showed that compared to free BSP (J = 25.98 ± 2.34 μg/cm(2)/h), all BSP ion-pair complexes displayed lower and controllable flux in the range of 0.11 to 4.19 μg/cm(2)/h. After forming ion-pair complexes, the capability of BSP to penetrate through skin was weakened due to the lowered log P and increased molecule weight. Accordingly, this study has demonstrated that the flux of BSP could be controlled by ion-pair strategy, and among all complexes investigated, BSP-M was the most promising candidate for long-acting transdermal patches.

摘要

对于长效透皮贴剂而言,具有中等药物渗透速率(通量)是理想的。在这项工作中,我们首创了一种通过离子对策略控制比索洛尔(BSP)通量的新型简单方法。制备了不同的离子对复合物,包括马来酸比索洛尔(BSP-M)、酒石酸比索洛尔、苯磺酸比索洛尔和富马酸比索洛尔,并分别在体外测定了它们通过兔腹部皮肤的通量。此外,还研究了异丙基肉豆蔻酸的渗透行为、DSC 测定的压敏胶中的溶解度指数以及正辛醇/水分配系数(log P),以阐明控制药物渗透速率的机制。结果表明,与游离 BSP(J = 25.98 ± 2.34 μg/cm(2)/h)相比,所有 BSP 离子对复合物的通量均较低且可控制,范围为 0.11 至 4.19 μg/cm(2)/h。形成离子对复合物后,由于 log P 降低和分子量增加,BSP 通过皮肤的渗透能力减弱。因此,本研究表明可以通过离子对策略控制 BSP 的通量,在所研究的所有复合物中,BSP-M 是长效透皮贴剂最有前途的候选药物。

相似文献

本文引用的文献

7
Poly(2-hydroxy-3-phenoxypropylacrylate, 4-hydroxybutyl acrylate, dibutyl maleate) membrane controlled clonidine zero-order release.
Eur J Pharm Biopharm. 2007 Jun;66(3):429-34. doi: 10.1016/j.ejpb.2006.11.005. Epub 2006 Nov 19.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验